CAP TODAY Pathology/Laboratory Medicine/Laboratory Management
April 14, 2021–Thermo Fisher Scientific announced the FDA has expanded emergency use authorization for the Applied Biosystems TaqPath COVID-19 Combo Kit to include the high-throughput Thermo Fisher Scientific Amplitude solution.
The Amplitude solution is a molecular diagnostic testing system that aims to help clinical labs expand their testing capacity by combining the company’s extraction and real-time PCR instruments with liquid-handling products from the Tecan Group. The modular system uses a high-throughput version of Thermo Fisher’s Applied Biosystems TaqPath COVID-19 Combo Kit, which received emergency use authorization in March 2020, to process samples in four steps. The platform can process up to 8,000 samples per day.
Pages: 1 2